377 related articles for article (PubMed ID: 33619245)
21. 'Geno-to-pheno' SARS-CoV-2 genome-COVID-19 association studies.
Tang JW
EBioMedicine; 2021 Apr; 66():103333. PubMed ID: 33857904
[No Abstract] [Full Text] [Related]
22. Canadian COVID-19 host genetics cohort replicates known severity associations.
Garg E; Arguello-Pascualli P; Vishnyakova O; Halevy AR; Yoo S; Brooks JD; Bull SB; Gagnon F; Greenwood CMT; Hung RJ; Lawless JF; Lerner-Ellis J; Dennis JK; Abraham RJS; Garant JM; Thiruvahindrapuram B; Jones SJM; ; Strug LJ; Paterson AD; Sun L; Elliott LT
PLoS Genet; 2024 Mar; 20(3):e1011192. PubMed ID: 38517939
[TBL] [Abstract][Full Text] [Related]
23. The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.
Zeberg H; Pääbo S
Nature; 2020 Nov; 587(7835):610-612. PubMed ID: 32998156
[TBL] [Abstract][Full Text] [Related]
24. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
Elife; 2021 Feb; 10():. PubMed ID: 33570490
[TBL] [Abstract][Full Text] [Related]
25. Pushing the boundaries with collision collaboration: the marriage of ideas.
Rathmell JC; Rathmell WK
J Clin Invest; 2021 Jan; 131(2):. PubMed ID: 33463534
[No Abstract] [Full Text] [Related]
26. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein.
Gao T; Gao Y; Liu X; Nie Z; Sun H; Lin K; Peng H; Wang S
BMC Microbiol; 2021 Feb; 21(1):58. PubMed ID: 33618668
[TBL] [Abstract][Full Text] [Related]
27. Mutations on COVID-19 diagnostic targets.
Wang R; Hozumi Y; Yin C; Wei GW
Genomics; 2020 Nov; 112(6):5204-5213. PubMed ID: 32966857
[TBL] [Abstract][Full Text] [Related]
28. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus.
Downes DJ; Cross AR; Hua P; Roberts N; Schwessinger R; Cutler AJ; Munis AM; Brown J; Mielczarek O; de Andrea CE; Melero I; ; Gill DR; Hyde SC; Knight JC; Todd JA; Sansom SN; Issa F; Davies JOJ; Hughes JR
Nat Genet; 2021 Nov; 53(11):1606-1615. PubMed ID: 34737427
[TBL] [Abstract][Full Text] [Related]
29. Found: genes that sway the course of the coronavirus.
Kaiser J
Science; 2020 Oct; 370(6514):275-276. PubMed ID: 33060342
[No Abstract] [Full Text] [Related]
30. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity.
Jiang X; Zhang Z; Wang C; Ren H; Gao L; Peng H; Niu Z; Ren H; Huang H; Sun Q
Signal Transduct Target Ther; 2020 Nov; 5(1):268. PubMed ID: 33203835
[No Abstract] [Full Text] [Related]
31. Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry.
Ragia G; Manolopoulos VG
Pharmacogenomics; 2020 Dec; 21(18):1311-1329. PubMed ID: 33243086
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
[TBL] [Abstract][Full Text] [Related]
33. Updated rapid risk assessment from ECDC on the risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA - first update.
Eurosurveillance editorial team
Euro Surveill; 2021 Jan; 26(3):. PubMed ID: 33478621
[No Abstract] [Full Text] [Related]
34. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
36. Androgen sensitivity gateway to COVID-19 disease severity.
Wambier CG; Goren A; Vaño-Galván S; Ramos PM; Ossimetha A; Nau G; Herrera S; McCoy J
Drug Dev Res; 2020 Nov; 81(7):771-776. PubMed ID: 32412125
[TBL] [Abstract][Full Text] [Related]
37. Preliminary analyses of scRNA sequencing and immunohistochemistry of children's lung tissues indicate the expression of SARS-CoV-2 entry-related genes may not be the key reason for the milder syndromes of COVID-19 in children.
Tao Y; Yang R; Wen C; Fan J; Ma J; He Q; Zhao Z; Song X; Chen H; Shi G; Yin M; Fang N; Zhang H; Chen H; Mo X
Clin Transl Med; 2021 May; 11(5):e300. PubMed ID: 34047474
[No Abstract] [Full Text] [Related]
38. Designing Epigenome Editors: Considerations of Biochemical and Locus Specificities.
Sen D; Keung AJ
Methods Mol Biol; 2018; 1767():65-87. PubMed ID: 29524129
[TBL] [Abstract][Full Text] [Related]
39. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte-depleting chemotherapy for aggressive hematologic malignancies in two patients with positive SARS-CoV-2 PCR.
Pelcovits A; Pandita A; Farmakiotis D; Egan P
Leuk Res; 2021 Jan; 100():106473. PubMed ID: 33285314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
